Currently holds a position at Catalyst Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Medical Officer | Catalyst Pharmaceuticals Inc | June 30, 2015 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-08 | 2023-12-06 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
50,000
-56.6%
14.02701,000 USD |
50,000 -56.6% | 14.02 | 701,000 USD | |
2022-12-08 | 2022-12-06 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
5,918
-16.1%
16.8599,718 USD |
5,918 -16.1% | 16.85 | 99,718 USD | |
2022-09-16 | 2022-09-14 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
88,000
-80.0%
15.691,380,544 USD |
88,000 -80.0% | 15.69 | 1,380,544 USD | |
2022-09-16 | 2022-09-14 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
55,000
-71.4%
15.65860,915 USD |
55,000 -71.4% | 15.65 | 860,915 USD | |
2022-06-23 | 2022-06-22 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
6,152
-21.8%
6.6140,646 USD |
6,152 -21.8% | 6.61 | 40,646 USD | |
2022-06-23 | 2022-06-21 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
143,848
-86.7%
6.60948,678 USD |
143,848 -86.7% | 6.60 | 948,678 USD | |
2021-12-08 | 2021-12-07 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
3,612
-14.1%
6.9925,237 USD |
3,612 -14.1% | 6.99 | 25,237 USD | |
2020-12-28 | 2020-12-22 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
3,668
-25.0%
3.4512,644 USD |
3,668 -25.0% | 3.45 | 12,644 USD | |
2019-11-27 | 2019-11-27 |
Catalyst Pharmaceuticals Inc
(CPRX)
|
S Sale |
100,000
-100.0%
4.66466,000 USD |
100,000 -100.0% | 4.66 | 466,000 USD |